Blimburn Seeds announced recently their expansion in the United States.
In a recent press release, Blimburn Seeds, one of the largest distributors in Europe (1) for cannabis seeds and clones, disclosed the opening of their new United States (US) e-commerce website. The distributor is bringing the growth of their operations with the newly expanded New York City (NYC) warehouse and another warehouse facility located in California. With these facilities, the company aims to provide their customers with product delivery within 2-5 days (1).
Blimburn Seeds began their business in Barcelona, Spain in 2002 (1). Over the last 20 years, the company has now expanded their operations into the US. With this expansion, Blimburn Seeds products will now offer US commercial cultivators and home-growers another option to purchase their seeds (1).
“We’re excited to launch this new website alongside the announcement of our new California operations and the expansion of our NYC warehouse to bring Blimburn’s legacy of quality and innovation directly to our U.S. customers,” Sergio Martinez, CEO of Blimburn Seeds commented (1). “This is more than just an expanded distribution center; it’s our commitment to meeting the needs of American growers with premium genetics, fast delivery, and guaranteed satisfaction. We’re proud to bring the full Blimburn experience to the U.S., supporting both experienced cultivators and newcomers to home-growing.”
In the press release, it delves into e-commerce’s product offerings which will allow US customers to purchase seeds with genetics that are best suited for their area’s growing conditions or for their own preferences (1). The hope with expanding their operations into the US is to hopefully inspire new cannabis cultivators to grow their own plants (1), “Whether for personal wellness, sustainable gardening, or commercial cultivation.” Further cannabis cultivation will help benefit the industry and move it forward.
To learn more (2), click here.
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
The Top 10 Articles from Cannabis Science and Technology in 2024
January 7th 2025It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2024. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!